FDA public consultation on draft guidance (Cell and Gene Therapy Catapult – Regulatory Round-up – Juin 2022)
Human Gene Therapy Products Incorporating Human Genome Editing | End Date: 14 Jul 2022 | Draft Guidance |
See all of Catapult’s Regulatory Round-up for June 2022 here.
Published on the 1st of July 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (27 octobre 2022). FDA public consultation on draft guidance (Cell and Gene Therapy Catapult – Regulatory Round-up – Juin 2022). ELSIBI. Consulté le 18 mars 2025 à l’adresse https://doi.org/10.58079/o645